Henrik Daub Person-Info 

( Ich bin Henrik Daub)

News

(1 - 4 von 16
)

KINAXO Enters Agreement with AstraZeneca

www.b3cnewswire.com
Dr. Henrik Daub, CTO at KINAXO commented: “Posttranslational modifications and their regulation are key factors in understanding cellular behavior and molecular drug action. We are delighted to apply our expertise to ...

Bio M Newsletter Fokus München Neugründungen Kinaxo ...

db.bio-m.org
Dr. Axel Ullrich und Dr. Henrik Daub. Der Schwerpunkt der Aktivitäten liegt auf der Entwicklung von hochspezifischen Kinase-Inhibitoren, die sich durch ein ...

KINAXO Announces European Patent Granted for its Chemical Proteomics...

www.bionity.com
KINAXO Biotechnologies GmbH announced that the European Patent Office has granted a patent entitled “Proteome-wide quantification of small molecule binding to...
Dossier exportieren
+1